NCT06722365

Brief Summary

The purpose of the study is to show if it's possible to use a special kind of ultrasound called backscatter quantitative ultrasound (bQUS) to check on a baby's lungs when the mother is 36 weeks pregnant. 16 participants will be on study for a single 30 minute ultrasound between 32 and 36 weeks of pregnancy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Dec 2024Jun 2026

First Submitted

Initial submission to the registry

December 3, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 9, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

December 17, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

February 13, 2026

Status Verified

February 1, 2026

Enrollment Period

1.5 years

First QC Date

December 3, 2024

Last Update Submit

February 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Enrolled as a Proxy for the Feasibility of bQUS to collect technically viable data

    Phase 1 will provide evidence of the technical viability of data acquisition at the UPH-Meriter CPC and will involve 5 participants. Technical challenges will be discussed with the research team and the supporting vendor (GE) to decide whether the technique is viable to move forward. In case the decision is favorable, recruitment will continue to complete 16 participants to estimate the populational variance of the quantitative features. If the decision is not favorable due to technical complications, the study will be terminated.

    data collected over a single study visit (up to 30 minutes)

Secondary Outcomes (1)

  • Population Variance in Fetal Lung Microstructure

    data collected over a single study visit (up to 30 minutes)

Study Arms (1)

36 Weeks Pregnant

Device: Backscatter Quantitative Ultrasound

Interventions

The intervention consists of a regular abdominal ultrasound scan for fetal evaluation. The difference with a regular scan is that the scanner used to image the fetus provides access to raw/unprocessed ultrasound echo data that can be extracted from the scanner and processed offline (after acquisition) to extract compute backscatter quantitative ultrasound (bQUS) features. Thus, data acquisition does not represent a significant departure from conventional fetal imaging protocols. Other than the time needed to acquire the images, the participant will not perceive any difference from a regular fetal ultrasound scan.

Also known as: Ultrasound, bQUS
36 Weeks Pregnant

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation

You may qualify if:

  • Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation.
  • Gestational age determined by the date of the last menses, and confirmed by measurement of the crown-rump-length on transabdominal ultrasound.

You may not qualify if:

  • Subjects unable to consent
  • Active Labor
  • Fetal malformations of the lungs
  • Prescription of corticosteroids prior to ultrasound evaluation
  • Pre-gestation or gestational diabetes mellitus
  • Low English proficiency, needing an interpreter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meriter Hospital

Madison, Wisconsin, 53715, United States

RECRUITING

MeSH Terms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • J. Igor Iruretagoyena, MD, MS

    UW School of Medicine and Public Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

UW Ob/Gyn Human Subjects Core

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2024

First Posted

December 9, 2024

Study Start

December 17, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 13, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data sharing with external collaborators will be provided through FlyWheel Exchange.

Time Frame
Coded data and the linking files will be stored for 7 years after conclusion of the study. After seven years, linking files and codes will be destroyed, and the de-identified data will be stored indefinitely for potential future research use.
Access Criteria
Permission to access data will be provided within Data Sharing Agreements and only after IRB approval.

Locations